Institutions / Soleus Capital Management, L.P. / Holdings
Back to Soleus Capital Management, L.P.

Soleus Capital Management, L.P.

All holdings · as of Dec 31, 2025

94 positions

CompanyClassValueShares% of portfolio
Terns Pharmaceuticals, Inc.—$8.59M212,7100.4%
CIDARA THERAPEUTICS INC—$8.57M38,8110.4%
INSMED INC—$8.44M48,5000.4%
CERUS CORP—$8.24M4,000,0000.3%
Erasca, Inc.ERASCommon Stock$8.04M2,162,1620.3%
Avalo Therapeutics, Inc.—$8.03M441,9780.3%
C4 Therapeutics, Inc.CCCCCommon Stock$7.27M3,803,9420.3%
Evolus, Inc.—$7.12M1,070,0000.3%
CG Oncology, Inc.—$7.06M170,0000.3%
AnaptysBio, Inc.—$6.54M135,0000.3%
BELITE BIO, INCBLTEADR$6.46M40,3540.3%
Structure Therapeutics Inc.GPCRADR$6.26M90,0000.3%
ABIVAX SA—$6.07M45,0000.3%
Oruka Therapeutics, Inc.—$5.76M190,0000.2%
MoonLake ImmunotherapeuticsMLTXCommon Stock$5.27M400,0000.2%
NeoGenomics Inc—$5.03M427,5040.2%
Natera, Inc.—$4.58M20,0000.2%
CalciMedica, Inc.CALCCommon Stock$4.51M683,9040.2%
Pulmonx Corp—$4.50M2,038,3230.2%
Cogent Biosciences, Inc.—$4.26M120,0000.2%
INDIVIOR PLC—$3.59M100,0000.2%
UROGEN PHARMA LTD—$3.51M150,0000.1%
Tyra Biosciences, Inc.—$3.29M125,0000.1%
Karyopharm Therapeutics Inc.—$3.24M440,0000.1%
ZYMEWORKS INC.—$2.63M100,0000.1%
Viking Therapeutics Inc—$2.46M70,0000.1%
QuidelOrtho Corp—$2.14M75,0000.1%
InspireMD, Inc.NSPRCommon Stock$2.05M1,150,0000.1%
Inhibrx Biosciences, Inc.—$1.98M25,0000.1%
Arcellx, Inc.—$1.96M30,0000.1%
Olema Pharmaceuticals, Inc.—$1.75M69,8740.1%
Bicara Therapeutics Inc.—$1.68M100,0000.1%
Kodiak Sciences Inc.KODCommon Stock$1.68M60,0000.1%
GRAIL, Inc.—$941.5K11,0000.0%
FRACTYL HEALTH, INC.GUTSCommon Stock$880.0K400,0000.0%
STAAR SURGICAL CO—$577.3K25,0000.0%
VERACYTE INC—$421.0K10,0000.0%
JASPER THERAPEUTICS INCJSPRCommon Stock$366.0K200,0000.0%
Quoin Pharmaceuticals Ltd.—$360.8K25,0000.0%
MADRIGAL PHARMACEUTICALS, INC.—$291.2K5000.0%
LB PHARMACEUTICALS INCLBRXCommon Stock$222.6K10,0000.0%
Dyne Therapeutics, Inc.—$195.6K10,0000.0%
DELCATH SYSTEMS, INC.—$101.0K10,0000.0%
Tango Therapeutics, Inc.—$88.6K10,0000.0%
← PrevPage 2 of 2Next →